Labshake search
Citations for R&D Systems :
2451 - 2500 of 3472 citations for 4' Trifluoromethoxy 5 trifluoromethyl 1 1' biphenyl 3 carboxylic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... Primary antibodies were added overnight at 1:100 for CD31 (AF3628, R&D Systems, Minneapolis, USA), 1:500 dilution for Iba1 (ab5076 ...
-
bioRxiv - Immunology 2023Quote: ... probed with anti-mouse Ms-RD-SARS-COV-2 (R&D Systems, MAB105401, 1:10 dilution) or anti-mouse H3 (Immune-Tech ...
-
bioRxiv - Cell Biology 2024Quote: ... Wnt3a was supplemented only on day 1 (25 ng/ml, R&D Systems, #5036-WN/CF). Thereafter ...
-
bioRxiv - Cell Biology 2024Quote: Primary antibodies used: goat anti-CD31 (1:500, Catalog # AF3628, R&D Systems, Inc. Minneapolis, MN). Isolectin b4 (1:250 ...
-
bioRxiv - Cell Biology 2024Quote: ... and Donkey Anti-Mouse IgG NorthernLights™ NL493-conjugated Antibody (1:100, NL009, R&D system) respectively ...
-
bioRxiv - Cell Biology 2024Quote: ... and 1 ng/mL human FGF basic/FGF2/bFGF (R&D Systems #233-FB-025/CF). After passage one ...
-
bioRxiv - Microbiology 2024Quote: ... 1×105 spirochetes were treated with 0–10 μM hSLPI (R&D Systems, #1274-PI-100) at 33°C for 48 h ...
-
bioRxiv - Microbiology 2024Quote: ... and incubated with 10 nM and 1 µM human SLPI (R&D Systems, #1274-PI-100) and murine SLPI (produced in lab as described above ...
-
bioRxiv - Developmental Biology 2024Quote: ... EPO and M-CSF using commercial Human CXCL12/SDF-1 alpha Quantikine ELISA (R&D Systems), LEGEND MAX™ Human Erythropoietin (EPO ...
-
bioRxiv - Immunology 2024Quote: ... 1% penicillin-streptomycin and 50 ng/mL recombinant human GM-CSF (R&D Systems, 215-MC). M1 macrophage differentiation medium was prepared using M1 macrophage culture medium supplemented with 100 ng/mL of LPS (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2024Quote: ... Primary antibodies for proteins of interest were anti-IL-33 (1:50, cat.no.AF3626, R&D Systems), anti-AdipoR2 (1:200 ...
-
bioRxiv - Immunology 2024Quote: ... was purchased from Peprotech (300-28A) and VCAM-1 (CD106 Fc chimera protein) from R&D Systems (862-VC-100). Calcium measurements were performed with Fura-2/AM (Molecular Probes ...
-
bioRxiv - Cancer Biology 2024Quote: ... 1% penicillin-streptomycin and 50 ng/mL recombinant human GM-CSF (R&D Systems 215-MC). M1 macrophage differentiation medium was prepared using M1 macrophage attachment medium supplemented with 100 ng/mL of LPS (Sigma-Aldrich L2630 ...
-
bioRxiv - Developmental Biology 2024Quote: The following antibodies were used for immunostaining: goat anti-PECAM1 (1:250, AF3628, R&D Systems), rabbit anti-DACH1 (1:100 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Antibodies used for immunoblotting and immunofluorescence studies included those for Gas1 (1:1000, R&D Systems, Inc ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 % P/S and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems). Passage 3 hMSCs were used in this study.
-
bioRxiv - Cell Biology 2024Quote: ... The recombinant human Shh N-terminal fragment (1 ng/ml; R&D Systems, #8908-SH-005) was then added to the same serum-free medium for 12 hours or overnight.
-
bioRxiv - Cancer Biology 2024Quote: ... DKK1 levels were measured using Human Dkk-1 Quantikine ELISA Kit (R&D systems, Cat# DKK100B), following the manufacturer’s instructions ...
-
bioRxiv - Developmental Biology 2024Quote: The following primary antibodies were used: sheep anti-ESGP/MymX (1:1000; R&D Systems; AF4580), mouse anti-MymK (Zhang et al ...
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 5 µg/ml anti-GM-CSF (MP122E9, R&D Systems) or 1 µg/ml anti-PECAM-1 (MEC13.3 ...
-
bioRxiv - Developmental Biology 2024Quote: ... media was replaced with 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Genetics 2024Quote: ... and 5 ng/ml recombinant human IL-15 (R&D Systems). After two days of activation ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 1X B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/mL GDF-5 (R&D Systems, Minneapolis, MN, USA), and 0.05 mM L-ascorbic acid 2-phosphate ...
-
bioRxiv - Microbiology 2020Quote: ... phosphorylated CREB (pCREB) and cleaved caspase-3 were measured using ELISA kits (R&D Systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Cell Biology 2022Quote: ... then plated into T175 flasks with Interleukin-3 (IL3, R&D Systems, 203-IL-050) and macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Cell Biology 2020Quote: ... and BMP4-Lif (10 ng/mL of mouse BMP-4 R&D Systems,Inc. ...
-
bioRxiv - Genomics 2020Quote: ... 4 μg normal rabbit IgG (R&D Systems, AB-105-C, lot: ER1212071) and ChIP-grade protein G magnetic beads (Cell Signalling 9006S ...
-
bioRxiv - Immunology 2022Quote: ... 30 μg/mL LPS plus 25 ng/mL IL-4 (R&D Systems); or 5 μg/mL LPS ...
-
bioRxiv - Cell Biology 2022Quote: ... and human bone morphogenetic protein 4 (hBMP4, 1.5 ng/ml; R&D Systems) together with human vascular endothelial growth factor (hVEGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...